Renovaro Biosciences Inc. (RENB)
NASDAQ: RENB · IEX Real-Time Price · USD
1.310
+0.060 (4.80%)
At close: Jul 26, 2024, 4:00 PM
1.340
+0.030 (2.29%)
After-hours: Jul 26, 2024, 4:59 PM EDT
Renovaro Biosciences Market Cap
Renovaro Biosciences has a market cap or net worth of $193.23 million as of July 26, 2024. Its market cap has increased by 473.39% in one year.
Market Cap
193.23M
Enterprise Value
201.49M
1-Year Change
473.39%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since December 11, 2018, Renovaro Biosciences's market cap has decreased from $252.00M to $193.23M, a decrease of -23.32%. That is a compound annual growth rate of -4.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 184.40M | -12.77% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G1 Therapeutics | 201.81M |
| Accuray | 201.47M |
| Biomea Fusion | 200.21M |
| Outlook Therapeutics | 199.42M |
| Inhibrx | 196.95M |
| Candel Therapeutics | 194.90M |
| Regencell Bioscience Holdings | 194.67M |
| Fractyl Health | 194.46M |